Alberto Espay Presents Promising Interim Results of Phase III Parkinson’s Study

Share

Alberto Espay, MD, examines John, who had recently undergone surgery as part of the Phase III Levodopa-Carbidopa Intestinal Gel clinical trial at UC Health University Hospital. Photo by Cindy Starr / Mayfield Clinic

Alberto Espay, MD, Director of Clinical Research at the James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders, on Thursday presented promising preliminary results of an ongoing, multi-site study of a continuous medication-delivery system for people with Parkinson’s disease. The delivery system is designed to reduce the severe on-again-off-again fluctuations that patients normally experience when taking levodopa orally, and at intervals, throughout the day.

Dr. Espay presented the early results from the 54-month, Phase III clinical trial of Abbott’s Levodopa-Carbidopa Intestinal Gel (LCIG) treatment system at the International Congress of Parkinson’s Disease and Movement Disorders in Toronto. Dr. Espay, an Assistant Professor of Neurology at UC, is a lead investigator in the clinical trial, whose study sites include the the UC Neuroscience Institute at University Hospital.

Patients participating in the study receive levodopa, which boosts dopamine in the brain, through a tube that leads directly into the duodenum, the first part of the small intestine. The medication is suspended as a stable gel from a cassette worn outside the body (photo below).

A news release from Abbott stated that patients reported improvement in motor symptoms after 12 weeks of treatment with the intestinal gel. They experienced a decrease in “off” time (a re-emergence of symptoms when medication is not working) and an increase in “on” time without dyskinesias, the involuntary movements associated with most treatments used to manage the disease.

“With advanced Parkinson’s disease, the goal of treatment is to provide patients with as much “on” time as possible, while limiting the troublesome dyskinesias they may experience,” Dr. Espay said in the news release. “The interim data from this study of LCIG show clinically meaningful improvements in these important measures.”

The interim report was based on data from 192 patients with advanced Parkinson’s disease who had completed 12 weeks of treatment with LCIG for 16 hours per day. Eleven of those 192 patients were treated by Dr. Espay’s team at the Gardner Center and University Hospital.

At 12 weeks, patients reported an average of 3.9 fewer hours of “off” time and 4.6 additional hours of “on” time without troublesome dyskinesias. Adverse events occurred in 168 patients (87.5 percent) and appeared to be largely related to the surgical procedure. Adverse events included abdominal pain (30.7 percent), complications of device insertion (21.4 percent) and procedural pain (17.7 percent).  The most severe complications from surgery were peritonitis (abdominal inflammation, 3.6 percent) and pneumoperitoneum (gas or air in the peritoneal cavity, 5.7 percent).  Fourteen patients (7.3 percent) withdrew because of an adverse event.

For more information about the Cincinnati portion of the study, please contact kristy.sullivan@uc.edu or call (513) 558-6517.

This entry was posted in UCNI Weekly Blog and tagged . Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • UCNI Weekly Blog
  • Join Our Email List
    for Weekly Updates

    Click here to continue.
  • Hope Stories

    • Courtney’s Story: Traumatic Spine Injury

      Courtney's Story: Traumatic Spine Injury Courtney is positive that she was wearing her seatbelt. Perhaps that is why her head and neck – thankfully -- were fine. Perhaps that is also why her midsection was so violently impacted, as the force of the rollover twisted...
    • Amber’s Story: Ruptured Aneurysm

      Amber's Story: Ruptured Aneurysm The only visible sign of Amber Gray’s ordeal is the long slender scar   that runs along her forearm. It is the area where a surgeon carefully   removed her radial artery, which was needed to bypass a damaged artery   in her...
    • Tim’s Story: Traumatic Brain Injury

      Tim's Story: Traumatic Brain Injury This story includes a graphic description of Tim’s traumatic brain injury. If you are squeamish or faint of heart, you may wish to close this file and turn to a different story of hope. Tim was outdoors doing what he liked...
    • Ameer’s Story: Pituitary Tumor

      Ameer's Story: Pituitary Tumor Ameer’s friends noticed the weight loss, and they kept asking him  about it. Was he OK? Ameer wasn’t concerned at first. Then he began to  notice that he couldn’t see people approaching him from the side. His  peripheral vision was...
    • Joe’s Story: Oligodendroglioma

      Joe's Story: Oligodendroglioma Joe calls it a miracle and a gift from “a higher power.” Others might call it a fortuitous turn of fate. Either way, Joe’s experience embodies a reversal of fortune that is both wonderful and startling. Once a man with...
    • Brian’s Story: Meningioma

      Brian's Story: Meningioma “Carefree” is the word Brian uses to describe his life back then. He was 39 years old, happily married and the father of three children under the age of 5. “Life was busy, but that felt normal,” he says, reflecting. “The only...
    • Jim’s Hope Story

      Eight years into his battle with Parkinson’s disease, Jim wasn’t doing well. The medications he was taking no longer kept the tremors at bay, and sometimes, while walking, he would freeze in place, unable to take another step. Jim could...
    • Kevin’s Story: Acoustic Neuroma

      Kevin's Story: Acoustic Neuroma Kevin was in his mid-40s when he began to notice that he wasn’t hearing quite as well as in the past. But the change was gradual, so he didn’t worry about it. A few years went by, and the hearing...
    • Alicia’s Story: Multiple Sclerosis

      Alicia’s Story: Multiple Sclerosis Alicia is living a life that is filled to the brim: she is a wife, a mother, a runner, and a full-time technical sales specialist with a doctoral degree. She is also a master at living with multiple sclerosis. Diagnosed in...
    • Alison’s Story: Ruptured Aneurysm following Neurotrauma

      Alison's Story: Ruptured Aneurysm following Neurotrauma She has completed medical school, has won the Flying Pig Marathon and has reached the summit of two of Colorado’s 14,000-foot peaks.Today Dr. Alison Delgado is tackling a mountain of a different kind. Step by hard-earned step, word by remembered...